SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES
🇮🇷Iran
- Country
- 🇮🇷Iran
- Ownership
- Private
- Established
- 1961-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sbmu.ac.ir/
Comparing the Efficacy of Two Neurofeedback Protocols for Generalized Anxiety Disorder
Not Applicable
Completed
- Conditions
- Generalized Anxiety Disorder
- Interventions
- Device: EEG Neurofeedback
- First Posted Date
- 2024-04-12
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT06361953
- Locations
- 🇮🇷
Shahid Beheshti University of Medical Science, Tehran, Iran, Islamic Republic of
Anti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple Myeloma
Phase 1
Not yet recruiting
- Conditions
- Multiple Myeloma, Refractory
- Interventions
- Biological: Anti-BCMA CAR-NK
- First Posted Date
- 2024-02-05
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 10
- Registration Number
- NCT06242249
- Locations
- 🇮🇷
Shariati Hospital, Tehran, Iran, Islamic Republic of
Topical Statin Eye Drop in the Management of the Dry Eye
Phase 1
Active, not recruiting
- Conditions
- Dry Eye Disease
- Interventions
- Drug: Statin eye dropDrug: Placebo
- First Posted Date
- 2024-01-17
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT06208384
- Locations
- 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of
Empagliflozin in Heart Failure Dialysis Patients
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 30
- Registration Number
- NCT05967156
- Locations
- 🇮🇷
Nooshin Dalili, Tehran, Iran, Islamic Republic of
Treatment Chronic UTI Post Kidney Transplant
Phase 3
Terminated
- Conditions
- Urinary Tract InfectionsTransplant-Related Disorder
- Interventions
- Biological: Phage
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 5
- Registration Number
- NCT05967130
- Locations
- 🇮🇷
Nooshin Dalili, Tehran, Iran, Islamic Republic of
Anterior Lens Capsule as a Spacer in the Deep Sclerectomy _ Phacoemulsification
Not Applicable
Active, not recruiting
- Conditions
- GlaucomaCataract
- Interventions
- Procedure: Non-penetrating deep sclerectomy and phacoemulsificationProcedure: Non-penetrating deep sclerectomy and phacoemulsification and autotransplantation of anterior lens capsule
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 66
- Registration Number
- NCT05906212
- Locations
- 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of
The Effect of Amantadine on Post-COVD-19 Fatigue
- First Posted Date
- 2022-12-28
- Last Posted Date
- 2022-12-28
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 83
- Registration Number
- NCT05667077
- Locations
- 🇮🇷
Shohada Tajrish Hospital, Tehran, Iran, Islamic Republic of
MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial
Early Phase 1
Completed
- Conditions
- Hypoxic Ischaemic Encephalopathy Due to Cardiac Arrest
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2022-11-18
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 35
- Registration Number
- NCT05621590
- Locations
- 🇮🇷
Shahid Beheshti University of Medical Sciences, Shohada Hospital, Tehran, Iran, Islamic Republic of
Additional Effect of Subthreshold Micropulse Laser to Intravitreous Injection of Bevacizumab on Diabetic Macular Edema
Phase 2
Active, not recruiting
- Conditions
- Diabetic Macular Edema
- Interventions
- Combination Product: Intravitreal bevacizumab injection with subthreshold micropulse laserDrug: Intravitreal bevacizumab injection alone
- First Posted Date
- 2022-10-17
- Last Posted Date
- 2022-10-17
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 30
- Registration Number
- NCT05582577
- Locations
- 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of
Pharmacological Treatment of Presbyopia
- First Posted Date
- 2022-10-04
- Last Posted Date
- 2022-10-04
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 75
- Registration Number
- NCT05564832
- Locations
- 🇮🇷
Hamideh Sabbaghi, Tehran, Iran, Islamic Republic of